What

Where

Who

When

Placement of electrical brain stimulation:  In rodent tests, they found that instead of the subthalmic nucleus — the area of the brain where the electrical implants are typically implanted — it's actually the axons, or neural wires, that connect the subthalmic nucleus to other parts of the brain, that are most impacted by stimulation

Stanford

Deisseroth, Karl

3/21/09

http://www.insidebayarea.com/localnews/ci_11967017

High cadence cycling exercise Theracycle users with Parkinson's disease find that they have:  Reduced rigidity and tremor;  Reduced bradykinesia;  Improved flexibility and balance; and Improved bladder and bowel function

Cleveland Clinic

Albert

http://www.theracycle.com/parkinsons/?gclid=CPzni5XMu5kCFQomgwodRjYu5A

Sound therapy:  Several small studies have suggested that music therapy can slow the progression of Parkinson's. One of the best-known clinical trials, from Italy, found that music therapy positively affected movement, emotions and quality of life among a small group of patients. Other research has suggested that some types of music can stimulate production of dopamine and serotonin, another neurochemical involved in Parkinson's

http://www.themedguru.com/articles/can_sound_slow_parkinsons-86121207.html

Electrical Stimulation of Spine!!!:  Working with lab mice, the research team attached electrodes to the spines of mice bred to have Parkinson’s and then zapped them with small jolts of electricity.  The result was tremendous, with the mice regaining a multitude of muscle movement, not previously seen by the researchers,

Duke

http://healthknowitall.net/technology/2009/03/19/duke-researchers-reveal-promising-parkinsons-treatment/

Care for Caregivers  Share Your Care is a non-profit agency that offers a safe place to have fun and meet friends while caregivers run errands, go to work, or a needed break.  Our mission is to provide quality day services as an alternative to institutional care.

Share Your Care

298-1700 ext 31

www.shareyourcare.org

Supplements

CoQ or not to CoQ? A new study reported in the Archives of Neurology published online (May, 14, 2007) suggests that CoQ10 may not provide benefits to individuals with Parkinson's disease. These findings contradict results from  earlier studies involving a high purity CoQ10 supplement, Vitaline(R) CoQ10.(1)(2) Richard M. Delany, M.D., FACC, and founder of Personalized Preventive Medicine, finds that a closer review of this latest study design reveals important weaknesses, including the use of a short study duration (3 months) and a low daily dosage (300 mg), and failure to use the clinically proven CoQ10 product, Vitaline CoQ10.

Creatine: N-Methyl-N-guanylglycine, is used by body builders.  In addition, a large clinical trial is being conducted by the NIH NINDS to evaluate creatine to determine if there is a slowing of clinical decline in PD patients defined by a combination of cognitive, physical, and quality of life measures. Active treatment will be compared to placebo control against a background of dopaminergic therapy and usual medical care

NIH NINDS

http://clinicaltrials.gov/ct2/show/NCT00449865?cond=%22Parkinsonian+Disorders%22&intr=%22Creatine%22&rank=1

Memantine, N-methyl-D-aspartic acid receptor antagonist, shows significant benefit over placebo for patients with Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB), and is well tolerated according to a multicentre, randomised, double-blind, placebo-controlled study. Memantine is known to provide benefits for cognitive function in patients with Alzheimer's disease, she explained. Therefore, it could have efficacy in treating symptoms of DLB and PDD, and might also improve motor functions that are typical of these patients,

Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden

Londos

http://www.docguide.com/news/content.nsf/news/852571020057CCF68525757B006BC8AC